MedTrace Logo

Nordic Bifurcation Study. How to Use Drug Eluting Stents (DES) in Bifurcation Lesions?

NCT00376571 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 413

Last updated 2026-01-02

No results posted yet for this study

Summary

How to use drug eluting stents (DES) in bifurcation lesions. A strategy of routine stenting of both main vessel and side branch versus a strategy of routine main vessel stenting and optional treatment of side branch. A randomized Nordic multicenter study including 400 patients with angina pectoris with clinical angiographic follow-up.

Conditions

Interventions

PROCEDURE

Percutaneous coronary intervention

Comparing treatment of either "no side branch treatment" versus "stenting of main vessel and side branch treatment"

Sponsors & Collaborators

  • Johnson & Johnson

    collaborator INDUSTRY

  • Aarhus University Hospital Skejby

    lead OTHER

Principal Investigators

  • Leif Thuesen, MD · Director, Cardiac Cath. Lab., Skejby Hospital, University of Aarhus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2005-06-30
Completion
2011-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00376571 on ClinicalTrials.gov